arrow
Y

Yan Li

daiyue district center for disease control and prevention
H指数:20
被引数:1,885

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial

sIPV在2月龄健康婴儿中的安全性与免疫原性:采用序贯免疫程序与bOPV结合的III期、随机、盲法、平行阳性对照临床试验

2026-03-030
OAAI
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage
2024-02-211
OA
Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease

在显性遗传性阿尔茨海默氏病中抗淀粉样 β 单克隆抗体的2/3期临床试验中,11C-PiB和18F-florbetapir PET的纵向头对头比较

2023-04-057
OA
Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease
2023-03-162
OA
CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease
2023-03-1350
OAAI
Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition

常染色体显性阿尔茨海默氏病的血浆胶质纤维酸性蛋白: 与a β-pet,神经变性和认知的关联

2022-12-2826
OA
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review

血浆淀粉样蛋白 β 测量在识别阿尔茨海默氏病淀粉样斑块中的性能: 文献综述

2022-12-2776
OAAI
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer's trial selection and disease monitoring
2022-12-01161
OAAI
Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease
2022-10-1324
OA